Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Vatalanib shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in HUVECs with and IC50 of 7
Takanashi Y
CAS Number: 1936422-33-1
PubMed PMID: 29496543
BAY-57-1293 has potent and resistance-breaking antiviral efficacy with potential for the treatment of potentially life-threatening HSV type 1 and 2 infections
Suplatast tosylate ustat Vatalanib shows the anti-proliferation effectSuplatast tosylate, also known as Suplatast tosilate, is a Th2 cytokine inhibitor which is used as an antiallergic drug. Often used in the treatment of Kimura's disease. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T cells mediated IL 9 gene expression in toluene 2, 4 diisocyanate sensitized rats. uplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3